Terms: = Ovarian cancer AND PSA AND Prognosis
18 results:
1. Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3'RACE and high-throughput sequencing.
Adamopoulos PG; Koukouzeli FΕ; Kontos CK; Scorilas A
Gene; 2020 Jul; 749():144708. PubMed ID: 32334022
[TBL] [Abstract] [Full Text] [Related]
2. Validation of a subclassification for high-risk prostate cancer in a prospective cohort.
Butler SS; Dee EC; Lamba N; Sha ST; Mahal BA; Whitbeck A; Makkar R; Wangoe J; Mouw KW; Nguyen PL; Muralidhar V
Cancer; 2020 May; 126(10):2132-2138. PubMed ID: 32073662
[TBL] [Abstract] [Full Text] [Related]
3. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
Scorilas A; Mavridis K
Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
[TBL] [Abstract] [Full Text] [Related]
4. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract] [Full Text] [Related]
5. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
Jonsson L; Gaber A; Ulmert D; Uhlén M; Bjartell A; Jirström K
Diagn Pathol; 2011 Sep; 6():91. PubMed ID: 21955582
[TBL] [Abstract] [Full Text] [Related]
6. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
[TBL] [Abstract] [Full Text] [Related]
7. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
[TBL] [Abstract] [Full Text] [Related]
8. Serum proteomics using mass spectrometry.
Hood BL; Malehorn DE; Conrads TP; Bigbee WL
Methods Mol Biol; 2009; 520():107-28. PubMed ID: 19381950
[TBL] [Abstract] [Full Text] [Related]
9. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
[TBL] [Abstract] [Full Text] [Related]
10. Proteomics of cancer of hormone-dependent tissues.
Tyson DR; Ornstein DK
Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
[TBL] [Abstract] [Full Text] [Related]
11. Human tissue kallikreins: the cancer biomarker family.
Paliouras M; Borgono C; Diamandis EP
Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179
[TBL] [Abstract] [Full Text] [Related]
12. Human tissue kallikrein gene family: applications in cancer.
Obiezu CV; Diamandis EP
Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
[TBL] [Abstract] [Full Text] [Related]
14. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
Yousef GM; Borgoño CA; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris ME; Roagna R; Sismondi P; Diamandis EP
Br J Cancer; 2002 Nov; 87(11):1287-93. PubMed ID: 12439719
[TBL] [Abstract] [Full Text] [Related]
15. Human tissue kallikreins: a family of new cancer biomarkers.
Diamandis EP; Yousef GM
Clin Chem; 2002 Aug; 48(8):1198-205. PubMed ID: 12142373
[TBL] [Abstract] [Full Text] [Related]
16. Clinical uses of tumor markers: a critical review.
Duffy MJ
Crit Rev Clin Lab Sci; 2001 Jun; 38(3):225-62. PubMed ID: 11451209
[TBL] [Abstract] [Full Text] [Related]
17. Prostate specific antigen (psa) in breast and ovarian cancer.
Kucera E; Kainz C; Tempfer C; Zeillinger R; Koelbl H; Sliutz G
Anticancer Res; 1997; 17(6D):4735-7. PubMed ID: 9494598
[TBL] [Abstract] [Full Text] [Related]
18. Nonprostatic sources of prostate-specific antigen.
Diamandis EP; Yu H
Urol Clin North Am; 1997 May; 24(2):275-82. PubMed ID: 9126224
[TBL] [Abstract] [Full Text] [Related]
